ARCH Venture Partners: VC Firm in United States

Investor Type	VC Firm
Type of Fund	Venture Capital Fund
Industries	Software (Web Marketplace Saas..) • Other • IT (& TMT) • Media • BioTech • AgroTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cloud Services (& Infrastructure) • Food & Beverage • Logistics (& Distribution) • Material Science • Medical Devices (& Hospital Services) • Robotics • Aerospace (& Defense) • DeepTech • Healthcare (& Wellness) • Investment Management • Consumer • Pharmaceutical (& Medicine)
Stages	Early,Seed, Series A, Series B
Investing	United States • United Kingdom • Canada • Japan • China • Switzerland • Singapore • Israel • Ireland
Investment Range	$50,000 - $150,000,000
Investment Sweet Spot	$25,000,000
Assets Under Management	$635,800,000

Who are the key investors at ARCH Venture Partners?

Who co-invests with ARCH Venture Partners?

What is ARCH Venture Partners?

ARCH Venture Partners is an established venture capital firm with a focus on seeding and advancing early-stage technology companies across a wide array of industries. Since its inception in 1986, ARCH has been at the forefront of identifying and supporting disruptive companies at the intersection of information technology, life sciences, and physical sciences.

With headquarters in Chicago, Illinois, ARCH manages a considerable portfolio consisting of companies that span sectors such as Software, IT & TMT, Media, BioTech, AgroTech, Business Solutions, FinTech & Financial services, Hardware & Manufacturing, Energy, CleanTech, A.I. & Big Data, HealthTech & Fitness, Cloud Services & Infrastructure, Food & Beverage, Logistics & Distribution, Material Science, Medical Devices & Hospital Services, Robotics, Aerospace & Defense, DeepTech, Healthcare & Wellness, Investment Management, Consumer, and Pharmaceutical & Medicine.

The fund operates with an investment range from 50,000 USD to 150,000,000 USD, with a preferred 'sweet spot' for investments around 25,000,000 USD.

ARCH is well-known for participating in various funding stages, including Early, Seed, Series A, and Series B rounds. They manage investments with assets under management amounting to approximately 635,800,000 USD.

ARCH's approach to investment is deeply rooted in the idea of catalyzing discoveries that can prevent, detect, and cure diseases, leveraging great science and building strong teams.

Their team looks for opportunities to drive growth in companies that have the potential to be transformative in their respective fields and work closely with entrepreneurs, offering advice, expertise, and access to a valuable network. The testimonials from CEOs and Chairs of companies in their portfolio highlight ARCH's commitment and unique ability to build dynamic and successful companies. ARCH's strategy and activities reflect their belief in the power of science and technology to provide groundbreaking solutions that address significant challenges and create lasting value.

What they say:

We are a venture firm committed to advancing health outcomes through scientific breakthroughs.

What we look for: We invest in life science discoveries aimed at preventing, detecting, and curing disease.

ARCH Venture Partners's investments on record

Semma Therapeutics	$114,000,000.00	Series B
KSQ Therapeutics	$80,000,000.00
Codiak Biosciences	$76,500,000.00	Series C
Scholar Rock	$47,000,000.00	Series C
AnchorDx	$28,000,000.00	Series B
Metacrine	$22,000,000.00	Series B
Pulmatrix	$10,000,000.00	Post Ipo Equity
Pulmatrix	$14,000,000.00	Series B
Pulmatrix	$30,000,000.00	Series B